Teracyte Analytics

Digitizing Biological Processes

Health Tech & Life Sciences
Active
Seed Caesarea, Israel Founded 2020
Last updated 2026-06-18
Total raised
$1.5M
Last: Seed 2022-01
Stage
Seed
Founded
2020
Headcount
19
HQ
Caesarea, Israel
Sector
Health Tech & Life Sciences

About

TeraCyte developed a platform for high throughput temporal analysis of live single-cells, based on proprietary array chips, an imaging system and analytical tools. The platform allows for capturing and retaining suspension cells in dedicated cell arrays and real-time monitoring of cell function with high sensitivity fluorescent imaging and a matching high resolution brightfield image.

TeraCyte’s AI models can distinguish between various cell types, count cells and identify cell-cell interactions. TeraCyte’s solution can be used for discovery, development and manufacturing of cell therapies, biological and small molecule drugs. TeraCyte is currently set to begin collaborations with cell therapy companies on the development of high value applications.

Funding history · 1 round · $1.5M total

2022-01

Q&A

What is Teracyte Analytics' primary focus?
Teracyte Analytics focuses on digitizing biological processes through a platform for high-throughput temporal analysis of live single-cells. This platform uses proprietary array chips, an imaging system, and analytical tools to monitor cell function in real-time.
When was Teracyte Analytics founded?
Teracyte Analytics was founded in March 2020.
How many employees does Teracyte Analytics currently have?
Teracyte Analytics has 11-50 employees.
What is the total amount of funding Teracyte Analytics has raised to date?
Teracyte Analytics has raised a total of $1,500,000.
When did Teracyte Analytics complete its last funding round and who was an investor?
Teracyte Analytics completed a Seed round in January 2022, with Israel Innovation Authority as an investor.
Who are the co-founders of Teracyte Analytics?
The co-founders of Teracyte Analytics are Yoav Nissan-cohen, who serves as CEO, and Gal Lenz, who serves as CTO.
What is Teracyte Analytics' primary sector?
Teracyte Analytics' primary sector is Health Tech & Life Sciences.
What technologies does Teracyte Analytics utilize in its platform?
Teracyte Analytics utilizes Simulation & Imaging, Semiconductors & Electronics, Chipsets, and Artificial Intelligence in its platform.

Team · 4

Founder · Co-founder & CEO
LinkedIn ↗
Founder · Co-founder & CTO
LinkedIn ↗
Member of the Board
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Simulation & ImagingSemiconductors & ElectronicsChipsetsArtificial Intelligence
Target customers
Healthcare & Life SciencesLife SciencesBiotechnologyPharmaceuticals
Business model
B2B

Tags

drug-developmentpredictive-analyticspharmaceuticalscellsbiotechnologycell-therapy
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)